Repeated sprint training in hypoxia induces specific skeletal muscle adaptations through S100A protein signaling

FASEB J. 2024 Apr 30;38(8):e23615. doi: 10.1096/fj.202302084RR.

Abstract

Athletes increasingly engage in repeated sprint training consisting in repeated short all-out efforts interspersed by short recoveries. When performed in hypoxia (RSH), it may lead to greater training effects than in normoxia (RSN); however, the underlying molecular mechanisms remain unclear. This study aimed at elucidating the effects of RSH on skeletal muscle metabolic adaptations as compared to RSN. Sixteen healthy young men performed nine repeated sprint training sessions in either normoxia (FIO2 = 0.209, RSN, n = 7) or normobaric hypoxia (FIO2 = 0.136, RSH, n = 9). Before and after the training period, exercise performance was assessed by using repeated sprint ability (RSA) and Wingate tests. Vastus lateralis muscle biopsies were performed to investigate muscle metabolic adaptations using proteomics combined with western blot analysis. Similar improvements were observed in RSA and Wingate tests in both RSN and RSH groups. At the muscle level, RSN and RSH reduced oxidative phosphorylation protein content but triggered an increase in mitochondrial biogenesis proteins. Proteomics showed an increase in several S100A family proteins in the RSH group, among which S100A13 most strongly. We confirmed a significant increase in S100A13 protein by western blot in RSH, which was associated with increased Akt phosphorylation and its downstream targets regulating protein synthesis. Altogether our data indicate that RSH may activate an S100A/Akt pathway to trigger specific adaptations as compared to RSN.

Keywords: HIF‐1α; OXPHOS; RSH; S100A13; exercise; glycolysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Physiological* / physiology
  • Adult
  • Exercise / physiology
  • Humans
  • Hypoxia* / metabolism
  • Male
  • Muscle, Skeletal* / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • S100 Proteins* / metabolism
  • Signal Transduction* / physiology
  • Young Adult

Substances

  • S100 Proteins
  • Proto-Oncogene Proteins c-akt

Grants and funding